Those are estimates of total infections, not seroprevalence studies. Which makes them a bit more unreliable. And they show 0.3-0.49% IFR which just a wee bit higher than your previous 0.1-0.3.
https://www.medrxiv.org/content/10.1101/2020.08.12.20173690v2
England seroprevalence study of 100,000 from April through The end of June. Calculated 0.9% IFR.
https://www.medrxiv.org/content/10.1101/2020.08.06.20169722v2
Spanish seroprevalence study of 61,000 up to July 15. IFR 0.8%.
As in the Nature article I linked previously, I trust the experts on this stuff, who are giving credence to the vast majority of seroprevalence and IFR studies that are estimating 0.5-1.0% IFR.
Not 0.1-0.3 IFR. You are, of course, welcome to make your own guesses based on your own numbers like before and/or pick outlier studies, but I’ll stick to what majority are currently showing.
Anyways, thanks for the link this time. Helps to actually see what you’re basing your opinion on.